<?properties open_access?>
<?DTDIdentifier.IdentifierValue -//NLM//DTD JATS (Z39.96) Journal Publishing DTD v1.1 20151215//EN?>
<?DTDIdentifier.IdentifierType public?>
<?SourceDTD.DTDName JATS-journalpublishing1.dtd?>
<?SourceDTD.Version 1.1?>
<?ConverterInfo.XSLTName jp2nlmx2.xsl?>
<?ConverterInfo.Version 1?>
<front>
  <journal-meta>
    <journal-id journal-id-type="nlm-ta">Bioinformatics</journal-id>
    <journal-id journal-id-type="iso-abbrev">Bioinformatics</journal-id>
    <journal-id journal-id-type="publisher-id">bioinformatics</journal-id>
    <journal-title-group>
      <journal-title>Bioinformatics</journal-title>
    </journal-title-group>
    <issn pub-type="ppub">1367-4803</issn>
    <issn pub-type="epub">1367-4811</issn>
    <publisher>
      <publisher-name>Oxford University Press</publisher-name>
    </publisher>
  </journal-meta>
  <article-meta>
    <article-id pub-id-type="pmcid">7320626</article-id>
    <article-id pub-id-type="doi">10.1093/bioinformatics/btaa228</article-id>
    <article-id pub-id-type="publisher-id">btaa228</article-id>
    <article-categories>
      <subj-group subj-group-type="heading">
        <subject>Applications Notes</subject>
        <subj-group subj-group-type="category-toc-heading">
          <subject>Databases and Ontologies</subject>
        </subj-group>
      </subj-group>
    </article-categories>
    <title-group>
      <article-title>MaveQuest: a web resource for planning experimental tests of human variant effects</article-title>
    </title-group>
    <contrib-group>
      <contrib contrib-type="author">
        <contrib-id contrib-id-type="orcid" authenticated="false">http://orcid.org/0000-0003-3554-0464</contrib-id>
        <name>
          <surname>Kuang</surname>
          <given-names>Da</given-names>
        </name>
        <xref ref-type="aff" rid="btaa228-aff1">b1</xref>
        <xref ref-type="aff" rid="btaa228-aff2">b2</xref>
        <xref ref-type="aff" rid="btaa228-aff3">b3</xref>
        <xref ref-type="aff" rid="btaa228-aff4">b4</xref>
      </contrib>
      <contrib contrib-type="author">
        <name>
          <surname>Weile</surname>
          <given-names>Jochen</given-names>
        </name>
        <xref ref-type="aff" rid="btaa228-aff1">b1</xref>
        <xref ref-type="aff" rid="btaa228-aff2">b2</xref>
        <xref ref-type="aff" rid="btaa228-aff3">b3</xref>
        <xref ref-type="aff" rid="btaa228-aff4">b4</xref>
      </contrib>
      <contrib contrib-type="author">
        <name>
          <surname>Li</surname>
          <given-names>Roujia</given-names>
        </name>
        <xref ref-type="aff" rid="btaa228-aff1">b1</xref>
        <xref ref-type="aff" rid="btaa228-aff2">b2</xref>
        <xref ref-type="aff" rid="btaa228-aff3">b3</xref>
        <xref ref-type="aff" rid="btaa228-aff4">b4</xref>
      </contrib>
      <contrib contrib-type="author">
        <name>
          <surname>Ouellette</surname>
          <given-names>Tom W</given-names>
        </name>
        <xref ref-type="aff" rid="btaa228-aff1">b1</xref>
        <xref ref-type="aff" rid="btaa228-aff2">b2</xref>
      </contrib>
      <contrib contrib-type="author">
        <name>
          <surname>Barber</surname>
          <given-names>Jarry A</given-names>
        </name>
        <xref ref-type="aff" rid="btaa228-aff1">b1</xref>
        <xref ref-type="aff" rid="btaa228-aff2">b2</xref>
      </contrib>
      <contrib contrib-type="author">
        <name>
          <surname>Roth</surname>
          <given-names>Frederick P</given-names>
        </name>
        <xref ref-type="corresp" rid="btaa228-cor1"/>
        <xref ref-type="aff" rid="btaa228-aff1">b1</xref>
        <xref ref-type="aff" rid="btaa228-aff2">b2</xref>
        <xref ref-type="aff" rid="btaa228-aff3">b3</xref>
        <xref ref-type="aff" rid="btaa228-aff4">b4</xref>
        <!--<email>fritz.roth@utoronto.ca</email>-->
      </contrib>
    </contrib-group>
    <contrib-group>
      <contrib contrib-type="editor">
        <name>
          <surname>Lu</surname>
          <given-names>Zhiyong</given-names>
        </name>
        <role>Associate Editor</role>
      </contrib>
    </contrib-group>
    <aff id="btaa228-aff1"><label>b1</label><institution>Donnelly Centre</institution>, University of Toronto, Toronto, ON M5S 3E1, <country country="CA">Canada</country></aff>
    <aff id="btaa228-aff2"><label>b2</label><institution>Department of Molecular Genetics</institution>, University of Toronto, Toronto, ON M5S 1A8, <country country="CA">Canada</country></aff>
    <aff id="btaa228-aff3"><label>b3</label><institution>Lunenfeld-Tanenbaum Research Institute</institution>, Sinai Health System, Toronto, ON M5G 1X5, <country country="CA">Canada</country></aff>
    <aff id="btaa228-aff4"><label>b4</label><institution>Department of Computer Science</institution>, University of Toronto, Toronto, ON M5T 3A1, <country country="CA">Canada</country></aff>
    <author-notes>
      <corresp id="btaa228-cor1">To whom correspondence should be addressed. <email>fritz.roth@utoronto.ca</email></corresp>
    </author-notes>
    <pub-date pub-type="epub" iso-8601-date="2020-04-06">
      <day>06</day>
      <month>4</month>
      <year>2020</year>
    </pub-date>
    <pub-date pub-type="ppub">
      <day>15</day>
      <month>6</month>
      <year>2020</year>
    </pub-date>
    <pub-date pub-type="pmc-release">
      <day>06</day>
      <month>4</month>
      <year>2020</year>
    </pub-date>
    <!-- PMC Release delay is 0 months and 0 days and was based on the <pub-date pub-type="epub"/>. -->
    <volume>36</volume>
    <issue>12</issue>
    <fpage>3938</fpage>
    <lpage>3940</lpage>
    <history>
      <date date-type="received">
        <day>23</day>
        <month>9</month>
        <year>2019</year>
      </date>
      <date date-type="rev-recd">
        <day>27</day>
        <month>1</month>
        <year>2020</year>
      </date>
      <date date-type="accepted">
        <day>01</day>
        <month>4</month>
        <year>2020</year>
      </date>
    </history>
    <permissions>
      <copyright-statement>© The Author(s) 2020. Published by Oxford University Press.</copyright-statement>
      <copyright-year>2020</copyright-year>
      <license license-type="cc-by" xlink:href="http://creativecommons.org/licenses/by/4.0/">
        <license-p>This is an Open Access article distributed under the terms of the Creative Commons Attribution License (<ext-link ext-link-type="uri" xlink:href="http://creativecommons.org/licenses/by/4.0/">http://creativecommons.org/licenses/by/4.0/</ext-link>), which permits unrestricted reuse, distribution, and reproduction in any medium, provided the original work is properly cited.</license-p>
      </license>
    </permissions>
    <self-uri xlink:href="btaa228.pdf"/>
    <abstract>
      <title>Abstract</title>
      <sec id="s1">
        <title>Summary</title>
        <p>Fully realizing the promise of personalized medicine will require rapid and accurate classification of pathogenic human variation. Multiplexed assays of variant effect (MAVEs) can experimentally test nearly all possible variants in selected gene targets. Planning a MAVE study involves identifying target genes with clinical impact, and identifying scalable functional assays for that target. Here, we describe MaveQuest, a web-based resource enabling systematic variant effect mapping studies by identifying potential functional assays, disease phenotypes and clinical relevance for nearly all human protein-coding genes.</p>
      </sec>
      <sec id="s2">
        <title>Availability and implementation</title>
        <p>MaveQuest service: <ext-link ext-link-type="uri" xlink:href="https://mavequest.varianteffect.org/">https://mavequest.varianteffect.org/</ext-link>. MaveQuest source code: <ext-link ext-link-type="uri" xlink:href="https://github.com/kvnkuang/mavequest-front-end/">https://github.com/kvnkuang/mavequest-front-end/</ext-link>.</p>
      </sec>
      <sec id="s4">
        <title>Supplementary information</title>
        <p><xref ref-type="supplementary-material" rid="sup1">Supplementary data</xref> are available at <italic>Bioinformatics</italic> online.</p>
      </sec>
    </abstract>
    <funding-group>
      <award-group award-type="grant">
        <funding-source>
          <institution-wrap>
            <institution>National Human Genome Research Institute</institution>
            <institution-id institution-id-type="DOI">10.13039/100000051</institution-id>
          </institution-wrap>
        </funding-source>
      </award-group>
      <award-group award-type="grant">
        <funding-source>
          <institution-wrap>
            <institution>National Institutes of Health Center</institution>
          </institution-wrap>
        </funding-source>
        <award-id>HG004233</award-id>
        <award-id>HG010461</award-id>
      </award-group>
      <award-group award-type="grant">
        <funding-source>
          <institution-wrap>
            <institution>Canada Excellence Research Chairs Program</institution>
            <institution-id institution-id-type="DOI">10.13039/501100002784</institution-id>
          </institution-wrap>
        </funding-source>
      </award-group>
      <award-group award-type="grant">
        <funding-source>
          <institution-wrap>
            <institution>Canadian Institutes of Health Foundation</institution>
          </institution-wrap>
        </funding-source>
      </award-group>
      <award-group award-type="grant">
        <funding-source>
          <institution-wrap>
            <institution>One Brave Idea Foundation</institution>
          </institution-wrap>
        </funding-source>
      </award-group>
    </funding-group>
    <counts>
      <page-count count="3"/>
    </counts>
  </article-meta>
</front>
<body>
  <sec>
    <title>1 Introduction</title>
    <p>Driven by the advancement of genomic sequencing technologies, and by rapid increases in the number of identified disease-related genes and variants (<xref rid="btaa228-B4" ref-type="bibr">Brunham and Hayden, 2013</xref>), clinical genetic testing is gaining increasingly broad use. An accompanying challenge is the frequent occurrence of (often extremely rare) variants that are difficult to interpret (<xref rid="btaa228-B2" ref-type="bibr">Blazer <italic>et al.</italic>, 2015</xref>). In ClinVar, a popular resource for submitting genetic variants seen in clinical settings, approximately 40% of all variants are missense variants (<xref rid="btaa228-B14" ref-type="bibr">Landrum <italic>et al.</italic>, 2016</xref>). Unfortunately, the majority of missense variants in ClinVar are now classified as ‘variants of uncertain significance’ (VUS) (<xref rid="btaa228-B25" ref-type="bibr">Starita <italic>et al.</italic>, 2017</xref>; <xref rid="btaa228-B29" ref-type="bibr">Weile and Roth, 2018</xref>), which makes any corresponding genetic tests not ‘clinically valid’ (<xref rid="btaa228-B10" ref-type="bibr">Hoffman-Andrews, 2017</xref>), where clinical validity is defined by the extent to which a genetic test reveals a patient’s clinical phenotype or risk (<xref rid="btaa228-B5" ref-type="bibr">Burke, 2014</xref>; <xref rid="btaa228-B11" ref-type="bibr">Holtzman and Watson, 1999</xref>). Many purely computational methods, such as Polyphen-2 (<xref rid="btaa228-B1" ref-type="bibr">Adzhubei <italic>et al.</italic>, 2010</xref>), have been established for predicting the functional effect of given variants. However, experimental functional assays can detect far more disease-associated variants with high confidence than can computational approaches (<xref rid="btaa228-B26" ref-type="bibr">Sun <italic>et al.</italic>, 2016</xref>). Functional evidence is also considered important under the American College of Medical Genetics and Genomics/Association for Molecular Pathology guidelines (<xref rid="btaa228-B20" ref-type="bibr">Richards <italic>et al.</italic>, 2015</xref>), and thus could help shift many VUS variants to more clinically useful categories (e.g. pathogenic or benign). However, conventional functional assays, such as complementation (<xref rid="btaa228-B18" ref-type="bibr">Osborn and Miller, 2007</xref>), are often resource-intensive, and results from such assays are not generally available for rare clinical VUS variants.</p>
    <p>Multiplexed assays of variant effect (MAVEs) provide a systematic, experimental approach to study nearly all missense variants in selected gene targets (<xref rid="btaa228-B25" ref-type="bibr">Starita <italic>et al.</italic>, 2017</xref>). Indeed, some variant effect maps have been shown to outperform smaller-scale validated <italic>in vitro</italic> functional assays in quantitatively predicting disease phenotypes (<xref rid="btaa228-B27" ref-type="bibr">Sun <italic>et al.</italic>, 2020</xref>).</p>
    <p>The growing interest in MAVE studies (<xref rid="btaa228-B29" ref-type="bibr">Weile and Roth, 2018</xref>) has presented bioinformatic challenges unique to the early planning stage. For example, to explore the clinical relevance of potential target genes and to identify scalable functional assays for these genes, information must be assembled from multiple database and literature resources. Here, we developed MaveQuest, a web-based service simplifying access to diverse aggregated information about potential functional assays, disease phenotypes and clinical relevance of genes for systematic variant effect mapping.</p>
  </sec>
  <sec>
    <title>2 The database</title>
    <p>The current version of the MaveQuest database curates literature for information related to 19 200 human genes from the Human Genome Organization’s Gene Nomenclature Committee collection (<xref rid="btaa228-B3" ref-type="bibr">Braschi <italic>et al.</italic>, 2019</xref>). Of these genes, MaveQuest identified cellular phenotypes (each having the potential to enable a scalable functional assay) for 18 979 genes, disease phenotypes for 8460 genes and evidence of clinical relevance for 5203 genes. <xref ref-type="fig" rid="btaa228-F1">Figure 1A</xref> presents the three categories of data sources that were included in the MaveQuest database.</p>
    <fig id="btaa228-F1" orientation="portrait" position="float">
      <label>Fig. 1.</label>
      <caption>
        <p>The architecture of MaveQuest. (<bold>A</bold>) Data from other sources were parsed and imported into the MaveQuest database and are retrieved by the API or the front-end user interface. (<bold>B</bold>) Three major components of the MaveQuest front-end service</p>
      </caption>
      <graphic xlink:href="btaa228f1"/>
    </fig>
    <p>The first data category points the user to potential functional assays. GenomeCRISPR (<xref rid="btaa228-B19" ref-type="bibr">Rauscher <italic>et al.</italic>, 2017</xref>), GenomeRNAi (<xref rid="btaa228-B22" ref-type="bibr">Schmidt <italic>et al.</italic>, 2013</xref>) and the Online Gene Essentiality (<xref rid="btaa228-B6" ref-type="bibr">Chen <italic>et al.</italic>, 2017</xref>) lead for human cell-based phenotypes that could form the basis of a scalable assay. The Human Reference Interactome Mapping project (<xref rid="btaa228-B16" ref-type="bibr">Luck <italic>et al.</italic>, 2020</xref>) provides information on assays to identify variants that ablate specific protein interactions or generally reduce protein folding or stability. Data from InParanoid (<xref rid="btaa228-B24" ref-type="bibr">Sonnhammer and Östlund, 2015</xref>), P-POD (<xref rid="btaa228-B9" ref-type="bibr">Heinicke <italic>et al.</italic>, 2007</xref>) and Alliance of Genome Resources (<xref rid="btaa228-B12" ref-type="bibr">Howe <italic>et al.</italic>, 2018</xref>) databases identify orthologs in non-human species, with links that allow the user to explore whether there are phenotypes associated with disruption of these orthologous genes that might be complemented by human genes to yield a scalable functional assay.</p>
    <p>The second category provides data on disease phenotypes with which the query gene has been associated. ClinVar (<xref rid="btaa228-B15" ref-type="bibr">Landrum <italic>et al.</italic>, 2018</xref>) provides clinically-interpreted variants reported for the query gene, which we can visualize to highlight regions enriched for pathogenic or benign variants, together with secondary structures, protein domains and families extracted from InterPro (<xref rid="btaa228-B17" ref-type="bibr">Mitchell <italic>et al.</italic>, 2019</xref>) and Uniprot (<xref rid="btaa228-B28" ref-type="bibr">UniProt Consortium, 2019</xref>) databases. To enable users to further evaluate the clinical significance of query genes, Online Mendelian Inheritance in Man (<xref rid="btaa228-B8" ref-type="bibr">Hamosh <italic>et al.</italic>, 2005</xref>), Orphanet (<xref rid="btaa228-B13" ref-type="bibr">INSERM, 1997</xref>), COSMIC Cancer Gene Census (<xref rid="btaa228-B23" ref-type="bibr">Sondka <italic>et al.</italic>, 2018</xref>) and PharmGKB (<xref rid="btaa228-B30" ref-type="bibr">Whirl-Carrillo <italic>et al.</italic>, 2012</xref>) databases summarize disease- and/or drug-related phenotypes, their mode of inheritance and, in some cases, molecular mechanisms.</p>
    <p>The third category contains sequencing panels from three clinical genetic testing providers, Invitae, Ambry and GeneDx, who have each contributed many variant interpretations to ClinVar. The presence of a query gene in clinical genetic sequencing panels from multiple providers suggests clinical interest.</p>
  </sec>
  <sec>
    <title>3 The application programming interface</title>
    <p>The application programming interface (API) serves as an intermediate between the database and the front-end web application. The API, based on the RESTful standard (<xref rid="btaa228-B21" ref-type="bibr">Richardson <italic>et al.</italic>, 2007</xref>), can be accessed directly using any common programming language. The API currently provides six functions (<xref ref-type="supplementary-material" rid="sup1">Supplementary Table S1</xref>) that could be further integrated with other MAVE resources as they emerge, e.g. MaveDB (<xref rid="btaa228-B7" ref-type="bibr">Esposito <italic>et al.</italic>, 2019</xref>.)</p>
  </sec>
  <sec>
    <title>4 The front-end web application</title>
    <p>The front-end interface—enabling queries related to functional assays, disease phenotypes and clinical interests—contains three components (<xref ref-type="fig" rid="btaa228-F1">Fig. 1B</xref>). The first component, which also serves as the starting page, is a search panel that allows users to look up genes using identifiers. The second component is the gene summary page which lists cell-based phenotypes, disease phenotypes and evidence of clinical interest for each query gene. When the user has searched for partial matches, this information is included for all matching genes. Users can select a specific gene to bring up a detail page. This is the third component, which contains all data in the database associated with that gene. The detail page includes an overview of variants in ClinVar database when available, displaying the distribution of single-nucleotide variants along the protein sequence. Secondary structures, protein domains and families are also visualized for users to identify potential ‘variational hotspots’ (i.e. regions where variants are enriched). This feature is particularly useful for studying large proteins, allowing prioritization of regions harboring more pathogenic or benign variants.</p>
  </sec>
  <sec sec-type="supplementary-material">
    <title>Supplementary Material</title>
    <supplementary-material content-type="local-data" id="sup1">
      <label>btaa228_Supplementary_Data</label>
      <media xlink:href="btaa228_supplementary_data.pdf">
        <caption>
          <p>Click here for additional data file.</p>
        </caption>
      </media>
    </supplementary-material>
  </sec>
</body>
<back>
  <ack id="ack1">
    <title>Acknowledgements</title>
    <p>The authors appreciate the help from members of the Roth Lab and others who tested MaveQuest and provided valuable feedback at various stages.</p>
    <sec>
      <title>Funding</title>
      <p>This work was supported by the National Human Genome Research Institute of the National Institutes of Health Center of Excellence in Genomic Science [HG004233 and HG010461]; the Canada Excellence Research Chairs Program; a Canadian Institutes of Health Foundation grant and the One Brave Idea Foundation. </p>
      <p><italic>Conflict of Interest</italic>: none declared. </p>
    </sec>
  </ack>
  <ref-list id="ref1">
    <title>References</title>
    <ref id="btaa228-B1">
      <mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Adzhubei</surname><given-names>I.A.</given-names></name></person-group><etal>et al</etal> (<year>2010</year>) 
<article-title>A method and server for predicting damaging missense mutations</article-title>. <source>Nat. Methods</source>, <volume>7</volume>, <fpage>248</fpage>–<lpage>249</lpage>.<pub-id pub-id-type="pmid">20354512</pub-id></mixed-citation>
    </ref>
    <ref id="btaa228-B2">
      <mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Blazer</surname><given-names>K.R.</given-names></name></person-group><etal>et al</etal> (<year>2015</year>) 
<article-title>Next-generation testing for cancer risk: perceptions, experiences, and needs among early adopters in community healthcare settings</article-title>. <source>Genet. Test. Mol. Biomarkers</source>, <volume>19</volume>, <fpage>657</fpage>–<lpage>665</lpage>.<pub-id pub-id-type="pmid">26539620</pub-id></mixed-citation>
    </ref>
    <ref id="btaa228-B3">
      <mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Braschi</surname><given-names>B.</given-names></name></person-group><etal>et al</etal> (<year>2019</year>) 
<article-title>Genenames.org: the HGNC and VGNC resources in 2019</article-title>. <source>Nucleic Acids Res</source>., <volume>47</volume>, <fpage>D786</fpage>–<lpage>D792</lpage>.<pub-id pub-id-type="pmid">30304474</pub-id></mixed-citation>
    </ref>
    <ref id="btaa228-B4">
      <mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Brunham</surname><given-names>L.R.</given-names></name>, <name name-style="western"><surname>Hayden</surname><given-names>M.R.</given-names></name></person-group> (<year>2013</year>) 
<article-title>Hunting human disease genes: lessons from the past, challenges for the future</article-title>. <source>Hum. Genet</source>., <volume>132</volume>, <fpage>603</fpage>–<lpage>617</lpage>.<pub-id pub-id-type="pmid">23504071</pub-id></mixed-citation>
    </ref>
    <ref id="btaa228-B5">
      <mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Burke</surname><given-names>W.</given-names></name></person-group> (<year>2014</year>) 
<article-title>Genetic tests: clinical validity and clinical utility</article-title>. <source>Curr. Protoc. Hum. Genet</source>., <volume>81</volume>, <fpage>9.15.1</fpage>–<lpage>9.15.8</lpage>.</mixed-citation>
    </ref>
    <ref id="btaa228-B6">
      <mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Chen</surname><given-names>W.-H.</given-names></name></person-group><etal>et al</etal> (<year>2017</year>) 
<article-title>OGEE v2: an update of the online gene essentiality database with special focus on differentially essential genes in human cancer cell lines</article-title>. <source>Nucleic Acids Res</source>., <volume>45</volume>, <fpage>D940</fpage>–<lpage>D944</lpage>.<pub-id pub-id-type="pmid">27799467</pub-id></mixed-citation>
    </ref>
    <ref id="btaa228-B7">
      <mixed-citation publication-type="other"><person-group person-group-type="author"><name name-style="western"><surname>Esposito</surname><given-names>D.</given-names></name></person-group><etal>et al</etal> (<year>2019</year>) MaveDB: an open-source platform to distribute and interpret data from multiplexed assays of variant effect. <italic>Genome Biol</italic>, <bold>20</bold>, <fpage>1</fpage>–<lpage>11</lpage>.</mixed-citation>
    </ref>
    <ref id="btaa228-B8">
      <mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Hamosh</surname><given-names>A.</given-names></name></person-group><etal>et al</etal> (<year>2005</year>) 
<article-title>Online Mendelian inheritance in man (OMIM), a knowledgebase of human genes and genetic disorders</article-title>. <source>Nucleic Acids Res</source>., <volume>33</volume>, <fpage>D514</fpage>–<lpage>D517</lpage>.<pub-id pub-id-type="pmid">15608251</pub-id></mixed-citation>
    </ref>
    <ref id="btaa228-B9">
      <mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Heinicke</surname><given-names>S.</given-names></name></person-group><etal>et al</etal> (<year>2007</year>) 
<article-title>The Princeton protein orthology database (P-POD): a comparative genomics analysis tool for biologists</article-title>. <source>PLoS One</source>, <volume>2</volume>, <fpage>e766</fpage>.<pub-id pub-id-type="pmid">17712414</pub-id></mixed-citation>
    </ref>
    <ref id="btaa228-B10">
      <mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Hoffman-Andrews</surname><given-names>L.</given-names></name></person-group> (<year>2017</year>) 
<article-title>The known unknown: the challenges of genetic variants of uncertain significance in clinical practice</article-title>. <source>J. Law Biosci</source>., <volume>4</volume>, <fpage>648</fpage>–<lpage>657</lpage>.<pub-id pub-id-type="pmid">29868193</pub-id></mixed-citation>
    </ref>
    <ref id="btaa228-B11">
      <mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Holtzman</surname><given-names>N.A.</given-names></name>, <name name-style="western"><surname>Watson</surname><given-names>M.S.</given-names></name></person-group> (<year>1999</year>) 
<article-title>Promoting safe and effective genetic testing in the United States. Final report of the task force on genetic testing</article-title>. <source>J. Child Fam. Nurs</source>., <volume>2</volume>, <fpage>388</fpage>–<lpage>390</lpage>.<pub-id pub-id-type="pmid">10795196</pub-id></mixed-citation>
    </ref>
    <ref id="btaa228-B12">
      <mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Howe</surname><given-names>D.G.</given-names></name></person-group><etal>et al</etal> (<year>2018</year>) 
<article-title>Model organism data evolving in support of translational medicine</article-title>. <source>Lab Anim</source>., <volume>47</volume>, <fpage>277</fpage>–<lpage>289</lpage>.</mixed-citation>
    </ref>
    <ref id="btaa228-B13">
      <mixed-citation publication-type="other">INSERM. (<year>1997</year>) <italic>Orphanet: An Online Database of Rare Diseases and Orphan Drugs</italic>
<ext-link ext-link-type="uri" xlink:href="http://www.orpha.net">http://www.orpha.net</ext-link> (20 March 2020, date last accessed).</mixed-citation>
    </ref>
    <ref id="btaa228-B14">
      <mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Landrum</surname><given-names>M.J.</given-names></name></person-group><etal>et al</etal> (<year>2016</year>) 
<article-title>ClinVar: public archive of interpretations of clinically relevant variants</article-title>. <source>Nucleic Acids Res</source>., <volume>44</volume>, <fpage>D862</fpage>–<lpage>D868</lpage>.<pub-id pub-id-type="pmid">26582918</pub-id></mixed-citation>
    </ref>
    <ref id="btaa228-B15">
      <mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Landrum</surname><given-names>M.J.</given-names></name></person-group><etal>et al</etal> (<year>2018</year>) 
<article-title>ClinVar: improving access to variant interpretations and supporting evidence</article-title>. <source>Nucleic Acids Res</source>., <volume>46</volume>, <fpage>D1062</fpage>–<lpage>D1067</lpage>.<pub-id pub-id-type="pmid">29165669</pub-id></mixed-citation>
    </ref>
    <ref id="btaa228-B16">
      <mixed-citation publication-type="other"><person-group person-group-type="author"><name name-style="western"><surname>Luck</surname><given-names>K.</given-names></name></person-group><etal>et al</etal> (<year>2020</year>) A reference map of the human binary protein interactome. <italic>Nature</italic>. doi: 10.1038/s41586-020-2188-x.</mixed-citation>
    </ref>
    <ref id="btaa228-B17">
      <mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Mitchell</surname><given-names>A.L.</given-names></name></person-group><etal>et al</etal> (<year>2019</year>) 
<article-title>InterPro in 2019: improving coverage, classification and access to protein sequence annotations</article-title>. <source>Nucleic Acids Res</source>., <volume>47</volume>, <fpage>D351</fpage>–<lpage>D360</lpage>.<pub-id pub-id-type="pmid">30398656</pub-id></mixed-citation>
    </ref>
    <ref id="btaa228-B18">
      <mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Osborn</surname><given-names>M.J.</given-names></name>, <name name-style="western"><surname>Miller</surname><given-names>J.R.</given-names></name></person-group> (<year>2007</year>) 
<article-title>Rescuing yeast mutants with human genes</article-title>. <source>Brief. Funct. Genomic. Proteomic</source>, <volume>6</volume>, <fpage>104</fpage>–<lpage>111</lpage>.<pub-id pub-id-type="pmid">17698857</pub-id></mixed-citation>
    </ref>
    <ref id="btaa228-B19">
      <mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Rauscher</surname><given-names>B.</given-names></name></person-group><etal>et al</etal> (<year>2017</year>) 
<article-title>GenomeCRISPR—a database for high-throughput CRISPR/Cas9 screens</article-title>. <source>Nucleic Acids Res</source>., <volume>45</volume>, <fpage>D679</fpage>–<lpage>D686</lpage>.<pub-id pub-id-type="pmid">27789686</pub-id></mixed-citation>
    </ref>
    <ref id="btaa228-B20">
      <mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Richards</surname><given-names>S.</given-names></name></person-group><etal>et al</etal>; On behalf of the ACMG Laboratory Quality Assurance Committee. (<year>2015</year>), 
<article-title>Standards and guidelines for the interpretation of sequence variants: a joint consensus recommendation of the American College of Medical Genetics and Genomics and the Association for Molecular Pathology</article-title>. <source>Genet. Med</source>., <volume>17</volume>, <fpage>405</fpage>–<lpage>424</lpage>.<pub-id pub-id-type="pmid">25741868</pub-id></mixed-citation>
    </ref>
    <ref id="btaa228-B21">
      <mixed-citation publication-type="other"><person-group person-group-type="author"><name name-style="western"><surname>Richardson</surname><given-names>L.</given-names></name></person-group><etal>et al</etal> (<year>2007</year>) <italic>RESTful Web Services.</italic> O’Reilly Media, Inc., Sebastopol, CA.</mixed-citation>
    </ref>
    <ref id="btaa228-B22">
      <mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Schmidt</surname><given-names>E.E.</given-names></name></person-group><etal>et al</etal> (<year>2013</year>) 
<article-title>GenomeRNAi: a database for cell-based and <italic>in vivo</italic> RNAi phenotypes, 2013 update</article-title>. <source>Nucleic Acids Res</source>., <volume>41(Database issue</volume>), <fpage>D1021</fpage>–<lpage>D1026</lpage>.<pub-id pub-id-type="pmid">23193271</pub-id></mixed-citation>
    </ref>
    <ref id="btaa228-B23">
      <mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Sondka</surname><given-names>Z.</given-names></name></person-group><etal>et al</etal> (<year>2018</year>) 
<article-title>The COSMIC cancer gene census: describing genetic dysfunction across all human cancers</article-title>. <source>Nat. Rev. Cancer</source>, <volume>18</volume>, <fpage>696</fpage>–<lpage>705</lpage>.<pub-id pub-id-type="pmid">30293088</pub-id></mixed-citation>
    </ref>
    <ref id="btaa228-B24">
      <mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Sonnhammer</surname><given-names>E.L.L.</given-names></name>, <name name-style="western"><surname>Östlund</surname><given-names>G.</given-names></name></person-group> (<year>2015</year>) 
<article-title>InParanoid 8: orthology analysis between 273 proteomes, mostly eukaryotic</article-title>. <source>Nucleic Acids Res</source>., <volume>43(Database issue</volume>), <fpage>D234</fpage>–<lpage>D239</lpage>.<pub-id pub-id-type="pmid">25429972</pub-id></mixed-citation>
    </ref>
    <ref id="btaa228-B25">
      <mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Starita</surname><given-names>L.M.</given-names></name></person-group><etal>et al</etal> (<year>2017</year>) 
<article-title>Variant interpretation: functional assays to the rescue</article-title>. <source>Am. J. Hum. Genet</source>., <volume>101</volume>, <fpage>315</fpage>–<lpage>325</lpage>.<pub-id pub-id-type="pmid">28886340</pub-id></mixed-citation>
    </ref>
    <ref id="btaa228-B26">
      <mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Sun</surname><given-names>S.</given-names></name></person-group><etal>et al</etal> (<year>2016</year>) 
<article-title>An extended set of yeast-based functional assays accurately identifies human disease mutations</article-title>. <source>Genome Res</source>., <volume>26</volume>, <fpage>670</fpage>–<lpage>680</lpage>.<pub-id pub-id-type="pmid">26975778</pub-id></mixed-citation>
    </ref>
    <ref id="btaa228-B27">
      <mixed-citation publication-type="other"><person-group person-group-type="author"><name name-style="western"><surname>Sun</surname><given-names>S.</given-names></name></person-group><etal>et al</etal> (<year>2020</year>) A proactive genotype-to-patient-phenotype map for cystathionine beta-synthase. <italic>Genome Med</italic>, <bold>12</bold>, <fpage>1</fpage>–<lpage>18</lpage>.</mixed-citation>
    </ref>
    <ref id="btaa228-B28">
      <mixed-citation publication-type="journal">UniProt Consortium. (<year>2019</year>) 
<article-title>UniProt: a worldwide hub of protein knowledge</article-title>. <source>Nucleic Acids Res</source>., <volume>47</volume>, <fpage>D506</fpage>–<lpage>D515</lpage>.<pub-id pub-id-type="pmid">30395287</pub-id></mixed-citation>
    </ref>
    <ref id="btaa228-B29">
      <mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Weile</surname><given-names>J.</given-names></name>, <name name-style="western"><surname>Roth</surname><given-names>F.P.</given-names></name></person-group> (<year>2018</year>) 
<article-title>Multiplexed assays of variant effects contribute to a growing genotype-phenotype atlas</article-title>. <source>Hum. Genet</source>., <volume>137</volume>, <fpage>665</fpage>–<lpage>678</lpage>.<pub-id pub-id-type="pmid">30073413</pub-id></mixed-citation>
    </ref>
    <ref id="btaa228-B30">
      <mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Whirl-Carrillo</surname><given-names>M.</given-names></name></person-group><etal>et al</etal> (<year>2012</year>) 
<article-title>Pharmacogenomics knowledge for personalized medicine</article-title>. <source>Clin. Pharmacol. Ther</source>., <volume>92</volume>, <fpage>414</fpage>–<lpage>417</lpage>.<pub-id pub-id-type="pmid">22992668</pub-id></mixed-citation>
    </ref>
  </ref-list>
</back>
